Europe Medical Gas Equipment Market Report

Europe Medical Gas Equipment Market Size

The europe medical gas equipment market size was valued at USD 6.70 billion in 2025. The market size in Europe was estimated at USD 7.25 billion in 2026. It is further projected to grow and be worth USD 13.40 billion by 2034, showcasing a CAGR of 8.0% between 2026 to 2034.

Medical gases are indispensable in various medical applications, including respiratory therapy, anesthesia, life support, and diagnostic imaging. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), the demand for medical gases has surged by 15% annually since 2020 due to the increasing prevalence of chronic respiratory diseases and the aftermath of the COVID-19 pandemic. As per the European Centre for Disease Prevention and Control (ECDC), respiratory conditions like chronic obstructive pulmonary disease (COPD) affect over 40 million Europeans, creating a sustained need for advanced medical gas solutions.

The growing aging populations in Europe and advancements in healthcare technologies are fuelling the demand for medical gas equipment. Germany, France, and the UK are at the forefront in the adoption of medical gas equipment due to their robust healthcare systems and high per capita healthcare spending. The European Commission’s Directorate-General for Health and Food Safety emphasizes that hospitals account for over 60% of medical gas equipment usage, particularly in intensive care units (ICUs) and operating theaters. Additionally, innovations such as portable oxygen concentrators and smart monitoring systems are propelling the European market expansion. As Europe prioritizes healthcare modernization and patient safety, the medical gas equipment market is poised to expand.

MARKET DRIVERS

Rising Prevalence of Chronic Respiratory Diseases in Europe

One of the primary drivers of the Europe medical gas equipment market is the increasing prevalence of chronic respiratory diseases, which has heightened the demand for oxygen therapy and related equipment. According to the European Respiratory Society, respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea affect over 65 million people across Europe, with COPD alone accounting for 300,000 deaths annually. The European Centre for Disease Prevention and Control (ECDC) highlights that these conditions are exacerbated by environmental factors like air pollution, which contributes to a 10% annual increase in respiratory-related hospital admissions. This growing patient pool necessitates advanced medical gas equipment, including oxygen concentrators and ventilators. Furthermore, government initiatives promoting early diagnosis and treatment have bolstered adoption rates. As healthcare providers prioritize respiratory care, the demand for reliable and efficient medical gas systems continues to surge.

Aging Population and Increased Healthcare Spending

Another significant driver is Europe’s aging population, which has led to a higher incidence of age-related medical conditions requiring medical gas interventions. Eurostat reports that over 20% of Europe’s population is aged 65 or above, a figure expected to rise to 30% by 2050. This demographic shift has increased the burden on healthcare systems, particularly in intensive care units (ICUs) and long-term care facilities. The European Commission’s Directorate-General for Health and Food Safety notes that healthcare spending in Europe exceeds 10% of GDP, with a significant portion allocated to critical care infrastructure. Hospitals, which account for 60% of medical gas equipment usage, are investing heavily in modernizing their facilities to accommodate elderly patients requiring oxygen therapy and anesthesia. Additionally, advancements in portable and home-based medical gas systems are addressing the needs of aging populations, further propelling market growth.

MARKET RESTRAINTS

Stringent Regulatory Framework

The European medical gas equipment market faces significant challenges due to the stringent regulatory framework governing medical devices. The European Union’s Medical Device Regulation (MDR), enforced by the European Medicines Agency, imposes strict safety, quality, and performance standards, increasing compliance costs for manufacturers. According to a 2022 report by the European Commission, approximately 20% of small and medium-sized enterprises (SMEs) in the medical device sector struggle to meet these requirements, resulting in delayed product launches. The MDR mandates extensive clinical evaluations and post-market surveillance, further complicating operations. MedTech Europe highlights that nearly 30% of companies experienced revenue losses due to delayed certifications under the new regulation. These challenges hinder innovation and expansion, particularly for smaller players in the market.

High Installation and Maintenance Costs

Another major restraint is the high cost associated with installing and maintaining medical gas systems. The European Investment Bank reports that hospitals in the EU spend an estimated €15 billion annually on medical infrastructure upgrades, including gas equipment. For instance, installing a centralized oxygen delivery system can cost up to €500,000 per facility, deterring investment in regions with constrained healthcare budgets. Additionally, maintenance costs account for about 15-20% of the initial installation expenses, as stated by the World Health Organization (WHO). This financial burden disproportionately affects rural and underfunded healthcare facilities, limiting their access to advanced equipment. With rising healthcare expenditures across Europe, budgetary constraints continue to impede widespread adoption of cutting-edge medical gas technologies, thereby restricting market growth.

MARKET OPPORTUNITIES

Increasing Demand for Home Healthcare Solutions

The rising demand for home healthcare solutions presents a significant opportunity for the European medical gas equipment market. According to Eurostat, the aging population in Europe is projected to reach 28% of the total population by 2050, driving the need for portable oxygen concentrators and other home-based medical gas systems. The European Commission highlights that home healthcare spending is expected to grow by 10% annually, fueled by government initiatives to reduce hospital readmissions and promote outpatient care. For instance, Germany’s Federal Ministry of Health reported a 15% increase in reimbursement for home oxygen therapy in 2022. This trend is further supported by advancements in lightweight and energy-efficient equipment, making it more accessible for patients. As healthcare shifts toward decentralized models, manufacturers can capitalize on this growing segment to expand their market presence.

Technological Advancements and Digital Integration

Technological advancements and digital integration in medical gas equipment offer another promising opportunity for the European market. The European Medicines Agency emphasizes the role of smart medical devices in enhancing patient safety and operational efficiency. For example, IoT-enabled gas delivery systems allow real-time monitoring, reducing wastage and ensuring precise oxygen flow. A report by the European Patent Office reveals that patent filings for smart medical technologies increased by 25% between 2019 and 2022, reflecting rapid innovation in this space. Additionally, the European Investment Bank projects that investments in digital health infrastructure will exceed €20 billion by 2025. These innovations not only improve clinical outcomes but also align with sustainability goals by optimizing resource utilization. Manufacturers adopting these technologies can gain a competitive edge while addressing evolving healthcare needs across Europe.

MARKET CHALLENGES

Supply Chain Disruptions and Raw Material Shortages

Supply chain disruptions and raw material shortages pose a significant challenge to the European medical gas equipment market. The European Commission reported in 2023 that nearly 40% of medical device manufacturers faced delays due to global supply chain bottlenecks, exacerbated by geopolitical tensions and the aftermath of the COVID-19 pandemic. Critical materials like stainless steel and aluminum, essential for manufacturing gas cylinders and pipelines, have seen price hikes of up to 30% since 2021, according to Eurostat. These challenges are further compounded by transportation constraints, with the International Transport Forum noting a 25% increase in freight costs across Europe. Such disruptions hinder timely production and delivery, impacting healthcare facilities reliant on uninterrupted access to medical gases. Addressing these vulnerabilities requires strategic investments in localized supply chains and inventory management.

Rising Environmental Regulations and Sustainability Pressures

The increasing focus on environmental regulations and sustainability is another major challenge for the European medical gas equipment market. The European Environment Agency mandates stricter emissions standards, pushing manufacturers to adopt eco-friendly practices. For instance, the EU’s Green Deal aims to reduce carbon emissions by 55% by 2030, compelling companies to redesign energy-intensive equipment like oxygen generators. However, transitioning to sustainable technologies requires substantial investment, with the European Investment Bank estimating an additional €10 billion annually for green innovations in the healthcare sector. Furthermore, improper disposal of medical gas cylinders contributes to environmental hazards, as highlighted by the World Health Organization. Balancing regulatory compliance with cost-effective production remains a critical hurdle for manufacturers striving to meet both environmental and operational goals.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By End-use Insights

The hospitals segment led the market in Europe and accounted for 60.6% of the European market share in 2025 due to the critical role of medical gases in surgeries, intensive care, and emergency treatments. According to the European Commission, over 70% of medical gas consumption occurs in hospitals, with centralized systems like manifolds and vacuum systems being indispensable. Additionally, the rising number of hospital beds that is estimated at 3.5 million across Europe, which is driving the demand for medical gas equipment in Europe. Hospitals are vital for ensuring uninterrupted gas supply, making them the largest end-use segment. Their importance is further underscored by the World Health Organization, which emphasizes that reliable medical gas infrastructure directly impacts patient survival rates during critical care.

REGIONAL ANALYSIS

Germany dominated the medical gas equipment market in Europe by holding 22.7% share of the European market in 2025. The advanced healthcare infrastructure, with over 1,900 hospitals equipped with cutting-edge medical gas systems, is majorly driving the German market growth. According to the German Medical Technology Association, Germany accounts for 30% of medical device production in Europe owing to the strong R&D investments and government support. Additionally, the aging population of Germany is projected to reach 21 million seniors by 2030, which increases demand for oxygen therapy and respiratory care. The emphasis on digital health integration further propels growth, making Germany a hub for innovation in medical gas equipment.

France is another major regional segment for medical gas equipment in Europe. The robust healthcare system of France is driving demand for centralized gas delivery systems and alarm systems. Eurostat notes that France allocates 11% of its GDP to healthcare, fostering investments in modern medical infrastructure. Furthermore, the French government’s focus on reducing hospital readmissions through home healthcare solutions boosts demand for portable oxygen cylinders and flowmeters. France’s strategic initiatives, such as the "Health Innovation 2030" plan, prioritize medical advancements, solidifying its position as a leader in adopting innovative medical gas technologies.

Italy is predicted to witness a promising CAGR in the European market during the forecast period. The extensive network of Italy with 1,200 hospitals and a growing emphasis on upgrading aging medical infrastructure are boosting the Italian medical gas equipment market growth. The European Industrial Gases Association highlights that Italy’s medical gas equipment market benefits from a high prevalence of chronic respiratory diseases, affecting over 6 million people annually. Investments in energy-efficient vacuum systems and air compressors further drive growth. Additionally, Italy’s strong manufacturing base supports domestic production, reducing reliance on imports. These factors, combined with increasing healthcare spending, position Italy as a key player in the European medical gas equipment market.

KEY MARKET PLAYERS

Companies playing a key role in the Europe medical gas equipment market include

• Air Products and Chemicals, Inc.
• The Linde Group
• Air Liquide
• Praxair, Inc.
• Taiyo Nippon Sanso Corp.
• SOL-SpA
• Airgas, Inc.
• Atlas Copco
• Messer Group
• GCE Holding AB
• Beacon Medaes
• Medical Gas Solutions Ltd.
• Matheson Tri-Gas
• Taiya Nippon Sanso
• Atlas Copco

MARKET RESTRAINTS

This research report on the European medical gas equipment market has been segmented and sub-segmented into the following categories.

By Product

• Medical Gases
• Medical Gas Mixtures
• Medical Gas Equipment

By Application

• Therapeutic
• Diagnostic
• Pharmaceutical Manufacturing and Research

By End-use

• Hospitals
• Clinics
• Ambulatory surgical centers
• Others

By Country

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe